ArborGen Holdings Limited is a New Zealand-based company listed on the main board of the New Zealand Stock Exchange (NZX:ARB). Approximately 70% of ArborGen Holdings' issued shares are held by US beneficial holders. ArborGen Holdings Directors David Knott of Knott Partners and Ranjan Tandon of Libra Funds LP are each substantial shareholders in ArborGen Holdings. As at 31 March 2019, Knott Partners & Associates and Libra Funds LP owns 28.3% and 17.6% respectively of ArborGen Holdings' issued share capital. In addition a further 3% is held by Independent Directors and management.

ArborGen Holdings’ sole operating business is ArborGen - a leading producer of tree seedling products and one of the largest providers of conventional and technology-enhanced seedlings to the forestry industry. With a long history of tree improvement research and expertise in forestry, ArborGen is developing products designed to meet the challenges facing the global commercial forestry industry.

Through innovations in both conventional breeding and biotechnology, we develop high-value seedling products that significantly improve the productivity of a given area of land by enabling our customers to grow trees that yield more wood per acre with greater consistency and quality in a shorter period of time. These advanced and technology-enhanced products are designed to improve growth rates, yields, stress tolerance, uniformity, wood quality and processing efficiency of trees.

Combining superior nursery management practices and methods, conventional tree breeding, species selection, advanced tree improvement and biotechnology to produce trait-specific superior trees, ArborGen is working to ensure that our customers get the most out of every tree they grow. 

 

Forward Looking Statements

There are statements in this website that are “forward looking statements.” As these forward-looking statements are predictive in nature, they are subject to a number of risks and uncertainties relating to ArborGen Holdings Limited, and our ArborGen investment, some of which are beyond our control. As a result of the foregoing, actual results and conditions may differ materially from those expressed or implied by such statements.  ArborGen’s risks and uncertainties include the economic conditions in the countries in which it operates and the wood product markets (commercial and residential, construction, pulp and paper etc), intellectual property protection, regulatory approvals, public and customer acceptance of genetically engineered products, customer adoption of advanced seedling products, the success of ArborGen’s research and development activities, weather conditions and biological matters. As a result of the foregoing, actual results and conclusions may differ materially from those expressed or implied by such statements.